2024 ทำไม keto itra drug interaction เยอะ

Objective: To provide a review of the mechanism of action, clinical efficacy, adverse effects, drug interactions, and therapeutic considerations associated with the use of a ketogenic diet to manage patients with intractable seizures.

Data sources: A MEDLINE search from January 1966 to the present and relevant articles from journals were reviewed.

Data synthesis: The ketogenic diet has been used as a treatment modality since the early 1920s to control intractable seizures. The exact mechanism of action is unknown. Overall, uncontrolled clinical studies have reported that approximately one-third of patients with intractable seizures have become seizure-free on the ketogenic diet. Common adverse events attributed to the diet include dehydration, gastrointestinal symptoms, hypoglycemia, as well as carnitine and vitamin deficiencies. Cognitive effects, hyperlipidemia, impaired neutrophil function, urolithiasis, optic neuropathy, osteoporosis, and protein deficiency may also occur in some patients. Carbohydrate content and drug formulation in the selection of medications while on the diet are important. Acetazolamide, phenobarbital, and valproic acid have been reported to interact with the ketogenic diet. Medications that cause carnitine deficiency or influence carbohydrate metabolism should also be used with caution. The carbohydrate content of drugs in various therapeutic classes is presented to aid in the selection of the most appropriate drug and formulation for patients on the ketogenic diet. The success of the diet in controlling intractable seizures is related to the patient's close adherence to the diet. Minimizing carbohydrate ingestion from medications along with a multidisciplinary team approach to the selection and monitoring of the diet are important to the success of the ketogenic diet in controlling seizures.

Conclusions: The ketogenic diet has shown promising results in controlling intractable seizures; however, carefully controlled clinical trials are needed to better assess the efficacy of the diet during its use and after discontinuation.

PubMed Disclaimer

Comment in

• The ketogenic diet: the need for a multidisciplinary approach. Howrie DL, Kraisinger M, McGhee HW, Crumrine PK, Katyal N. Howrie DL, et al. Ann Pharmacother. 1998 Mar;32(3):384-5. doi: 10.1345/aph.17201. Ann Pharmacother. 1998. PMID: 9533070 No abstract available.

Similar articles

• Ketogenic diet efficacy in the treatment of intractable epileptic spasms. Kayyali HR, Gustafson M, Myers T, Thompson L, Williams M, Abdelmoity A. Kayyali HR, et al. Pediatr Neurol. 2014 Mar;50(3):224-7. doi: 10.1016/j.pediatrneurol.2013.11.021. Epub 2013 Dec 4. Pediatr Neurol. 2014. PMID: 24433856
• The Anticonvulsant Effects of Ketogenic Diet on Epileptic Seizures and Potential Mechanisms. Zhang Y, Xu J, Zhang K, Yang W, Li B. Zhang Y, et al. Curr Neuropharmacol. 2018;16(1):66-70. doi: 10.2174/1570159X15666170517153509. Curr Neuropharmacol. 2018. PMID: 28521671 Free PMC article. Review.
• The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH. Neal EG, et al. Lancet Neurol. 2008 Jun;7(6):500-6. doi: 10.1016/S1474-4422(08)70092-9. Epub 2008 May 2. Lancet Neurol. 2008. PMID: 18456557 Clinical Trial.
• Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Kinsman SL, Vining EP, Quaskey SA, Mellits D, Freeman JM. Kinsman SL, et al. Epilepsia. 1992 Nov-Dec;33(6):1132-6. doi: 10.1111/j.1528-1157.1992.tb01770.x. Epilepsia. 1992. PMID: 1464275
• [Effectiveness of a ketogenic diet in children with refractory epilepsy: a systematic review]. Araya-Quintanilla F, Celis-Rosati A, Rodriguez-Leiva C, Silva-Navarro C, Silva-Pinto Y, Toro-Jeria B. Araya-Quintanilla F, et al. Rev Neurol. 2016 May 16;62(10):439-48. Rev Neurol. 2016. PMID: 27149186 Review. Spanish.

Cited by

• Ketogenic therapy in childhood and adolescence: recommendations of the Brazilian experts group. de Brito Sampaio LP, Henriques-Souza AMM, Lin K, Neri LCL, Inuzuka LM, Uchôa LIL, Gregório MMO, Guilhoto LM, Montenegro MA, Lunardi M, Veiga M, de Lima PA, Braatz V. de Brito Sampaio LP, et al. Arq Neuropsiquiatr. 2023 Jun;81(6):597-606. doi: 10.1055/s-0043-1768676. Epub 2023 Jun 28. Arq Neuropsiquiatr. 2023. PMID: 37379871 Free PMC article.
• A Review of the Multi-Systemic Complications of a Ketogenic Diet in Children and Infants with Epilepsy. Newmaster K, Zhu Z, Bolt E, Chang RJ, Day C, Mhanna A, Paudel S, Farooq O, Swaminathan A, Acharya P, Cheungpasitporn W, Gupta S, Samanta D, Mahfooz N, Mainali G, Carney PR, Naik S. Newmaster K, et al. Children (Basel). 2022 Sep 10;9(9):1372. doi: 10.3390/children9091372. Children (Basel). 2022. PMID: 36138681 Free PMC article. Review.
• Weight loss programmes using low carbohydrate diets to control the cardiovascular risk in adolescents (Review). Stoica RA, Diaconu CC, Rizzo M, Toth PP, Stefan SD, Serafinceanu C, Nikolic D, Poiana C, Ionescu-Tirgoviste C, Pantea-Stoian A. Stoica RA, et al. Exp Ther Med. 2021 Jan;21(1):90. doi: 10.3892/etm.2020.9522. Epub 2020 Nov 26. Exp Ther Med. 2021. PMID: 33363601 Free PMC article. Review.
• M-Channel Activation Contributes to the Anticonvulsant Action of the Ketone Body β-Hydroxybutyrate. Manville RW, Papanikolaou M, Abbott GW. Manville RW, et al. J Pharmacol Exp Ther. 2020 Feb;372(2):148-156. doi: 10.1124/jpet.119.263350. Epub 2019 Nov 22. J Pharmacol Exp Ther. 2020. PMID: 31757819 Free PMC article.

Decreased carbon shunting from glucose toward oxidative metabolism in diet-induced ketotic rat brain.

ข้อใดเป็น Pharmacodynamic Drug Interaction

3. Pharmacodynamic Interactions คือ ปฏิกิริยาที่เกิดขึ้นบริเวณ effector sites โดยที่ยาตัวหนึ่งอาจจะมี enhancing effects ในขณะที่ยาตัวอื่นมี inhibitory effects. - enhancing effect บางครั้งใช้ additive, agonistic หรือ synergistic. - inhibitory effect บางครั้งใช้ antagonistic หรือ competitive.

Warfarin Drug Interaction มีอะไรบ้าง

- ยาที่ใช้ร่วมกันทาใ ้เพิ่มฤทธิ์ Warfarin: Amiodarone, Bactrim, Ciprofloxacin, Levofloxacin, Norfloxacin, Ofloxacin, Moxifloxacin, Gatifloxacin, Azithromycin, Clarithromycin, Erythromycin, Metronidazole, Fluconazole, Itraconazole, Ketoconazole, Miconazole, Econazole, Voriconazole, Cimetidine, Simvastatin, Fluvastatin, ...

ผู้ป่วยที่ได้รับยา warfarin ควรระวังการได้รับยาแอสไพริน เพราะเหตุใด

4.1 ภาวะอันตรกิริยาระหว่างยาที่เกิดจากกลไกทางเภสัชพลศาสตร์ (pharmacodynamic, PD) โดยยานี้ อาจจะเสริมฤทธิ์หรือท าให้การออกฤทธิ์ลดลงก็ได้เช่น การให้ยา warfarin ร่วมกับ aspirin จะท าให้การออกฤทธิ์ ของ warfarin ดีขึ้นจนอาจท าให้เกิดผลข้างเคียงคือท าให้เกิดเลือดออกผิดปกติได้ หากให้ยาขยายหลอดลมกลุ่ม beta-2 agonists เช่น ...